Published in Hepatitis Weekly, February 15th, 1999
Patients who receive liver transplants for hepatitis C virus (HCV)-related cirrhosis usually remain anti-HCV-seropositive after transplantation. The aim of this study was to characterize, longitudinally, the profile of HCV-specific antibodies and cryoglobulins in liver transplant recipients with recurrent HCV infection ("Antibodies to Hepatitis C Virus Envelope Proteins Correlate with Hepatitis C Viremia After Liver Transplantation," Transplantation, January 1999;67(1):78-84).
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.